The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

With enough supplies, Israel looks to re-route AstraZeneca vaccine delivery

Wed, 21st Apr 2021 10:45

* Israel bought enough vaccine from others, official says

* Seeks to divert AstraZeneca shipment to other countries

* Israel's vaccine rollout one of the fastest in the world

JERUSALEM, April 21 (Reuters) - Israel no longer wants
AstraZeneca's COVID-19 vaccine and is exploring with the
company whether a big shipment in the pipeline could be sent
elsewhere, Israel's pandemic coordinator said on Wednesday.

"We are trying to find the best solution. After all, we
don't want (the vaccines) to get here and have to throw them
into the trash," the official, Nachman Ash, told Army Radio,
saying Israel's needs were being met by other suppliers.

In his remarks, Ash made no reference to AstraZeneca’s
vaccine having been associated with very rare blood clots in
Europe. Many countries there resumed administering it after the
European Union's drug watchdog said benefits outweighed risks.

Israel cast a wide net last year when trying to secure
vaccine doses at the height of the pandemic and pre-ordered from
a number of companies.

It largely settled on the Pfizer/BioNTech
vaccine, launching one of the world's swiftest rollouts.
COVID-19 infections in Israel have dropped dramatically and the
economy has reopened.

Israel is also buying the COVID-19 vaccines from Moderna
, which uses a similar messenger RNA (mRNA) technology.

Ash said that with supplies secure through 2022, Israel no
longer required the 10 million doses it agreed to purchase from
AstraZeneca.

"They can certainly be used in other places in the world. At
the moment, we are trying to find, along with the company, the
best way to do this," he said.

"We believe it would be best if they (the vaccines) did not
come to Israel and we agree with the company on some sort of way
to divert them elsewhere."

Officials at AstraZeneca had no immediate comment.

Around 81% of Israeli citizens or residents over 16 - the
age group eligible for the Pfizer/BioNTech vaccine in Israel -
have received both doses.

Some 167,000 of the 5.2 million Palestinians in the occupied
West Bank and Islamist Hamas-run Gaza have had at least one dose
of vaccine, with supplies coming in from Israel, Russia, the
United Arab Emirates, the global COVAX vaccine-sharing programme
and China.
(Reporting by Jeffrey Heller and Ari Rabinovitch. Editing by
Mark Potter)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.